Boenning & Scattergood, Inc. Gilead Sciences, Inc. Transaction History

Boenning & Scattergood, Inc.

$622 Million
Q4 2022

A detailed history of Boenning & Scattergood, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Boenning & Scattergood, Inc. holds 3,744 shares of GILD stock, worth $329,771. This represents 0.04% of its overall portfolio holdings.

Number of Shares

3,744

Previous 4,269 12.3%

Holding current value

$329,771

Previous $263,000 15.21%

% of portfolio

0.04%

Previous 0.05%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 25, 2023	SELL	$62.32 - $89.47 $32,718 - $46,971	-525 Reduced 12.3%	3,744 $223,000
Q2 2022 Jul 13, 2022	BUY	$57.72 - $65.01 $30,303 - $34,130	525 Added 14.02%	4,269 $264,000
Q1 2022 Apr 14, 2022	SELL	$57.92 - $72.58 $321,745 - $403,181	-5,555 Reduced 59.74%	3,744 $223,000
Q4 2021 Jan 18, 2022	SELL	$64.88 - $73.64 $108,349 - $122,978	-1,670 Reduced 15.22%	9,299 $675,000
Q3 2021 Oct 21, 2021	BUY	$67.69 - $73.03 $36,484 - $39,363	539 Added 5.17%	10,969 $766,000
Q2 2021 Jul 21, 2021	SELL	$63.47 - $69.35 $949,828 - $1.04 Million	-14,965 Reduced 58.93%	10,430 $718,000
Q1 2021 Apr 22, 2021	BUY	$60.0 - $68.46 $899,580 - $1.03 Million	14,993 Added 144.14%	25,395 $1.64 Million
Q4 2020 Jan 20, 2021	SELL	$56.65 - $64.55 $329,986 - $376,003	-5,825 Reduced 35.9%	10,402 $606,000
Q3 2020 Oct 21, 2020	BUY	$62.1 - $78.08 $422,280 - $530,944	6,800 Added 72.13%	16,227 $1.03 Million
Q2 2020 Jul 14, 2020	SELL	$72.34 - $84.0 $1.25 Million - $1.45 Million	-17,254 Reduced 64.67%	9,427 $725,000
Q1 2020 Apr 13, 2020	SELL	$62.63 - $80.22 $48,663 - $62,330	-777 Reduced 2.83%	26,681 $2 Million
Q4 2019 Jan 15, 2020	BUY	$61.62 - $67.78 $268,355 - $295,181	4,355 Added 18.85%	27,458 $1.78 Million
Q3 2019 Oct 15, 2019	SELL	$62.51 - $69.0 $66,885 - $73,830	-1,070 Reduced 4.43%	23,103 $1.46 Million
Q2 2019 Jul 15, 2019	SELL	$61.87 - $69.38 $263,380 - $295,350	-4,257 Reduced 14.97%	24,173 $1.63 Million
Q1 2019 Apr 22, 2019	BUY	$62.53 - $70.05 $516,122 - $578,192	8,254 Added 40.91%	28,430 $1.85 Million
Q4 2018 Jan 22, 2019	BUY	$60.54 - $79.0 $10,897 - $14,220	180 Added 0.9%	20,176 $1.26 Million
Q3 2018 Oct 05, 2018	SELL	$71.28 - $78.92 $40,986 - $45,379	-575 Reduced 2.8%	19,996 $1.54 Million
Q2 2018 Aug 13, 2018	BUY	$64.88 - $75.68 $1.33 Million - $1.56 Million	20,571 New	20,571 $1.46 Million

Others Institutions Holding GILD

# of Institutions

1,893

Shares Held

1.02B

Call Options Held

12M

Put Options Held

9.04M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Boenning & Scattergood, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Boenning & Scattergood, Inc. with notifications on news.

Account

Boenning & Scattergood, Inc. Gilead Sciences, Inc. Transaction History